Literature DB >> 2411555

Immunoquantification of epoxide hydrolase and cytochrome P-450 isozymes in fetal and adult human liver microsomes.

T Cresteil, P Beaune, P Kremers, C Celier, F P Guengerich, J P Leroux.   

Abstract

Epoxide hydrolase and three cytochrome P-450 isozymes were immunochemically determined in microsomes from adult and fetal human liver and tentatively correlated with some enzyme activities. The P-450 isozymes 5, 8 and 9 present in adult liver could not be positively correlated with the total cytochrome P-450 concentration spectrophotometrically determined. In fetal liver microsomes, isozyme 8 could not be detected by either electrophoretic or immunochemical procedures. Isozyme 5 was the major isozyme present in the fetal liver and its concentration increased in close relation with the total P-450 level. As shown previously, arylhydrocarbon hydroxylase activity was related to the concentration of isozyme 8 in adult liver. In fetal preparations, the absence of isozyme 8 was associated with a very low arylhydrocarbon hydroxylase activity. Aldrin epoxidase and benzphetamine-N-demethylase activities were correlated with isozyme 5 concentration, but with different slopes for adult and fetal microsomes: adult preparations catalyzed these two reactions more efficiently. Conversely, the dehydroepiandrosterone 16 beta-hydroxylase, also associated with isozyme 5 concentration, was more active in fetal than in adult microsomes. Moreover, if acetanilide hydroxylase increased with isozyme 5 concentration in adult samples, no correlation occurred between activity and P-450 isozyme level in fetal microsomes. Hydroxylations of lauric acid in positions 11 and 12 and of dehydroepiandrosterone in position 16 alpha increased with total P-450 concentration but not with isozyme concentrations whatever the age considered. Lastly, epoxide hydrolase activity towards benzopyrene 4,5-oxide was closely associated with its immunochemically determined level. These results clearly suggest that multiple mechanisms are involved in the regulation of different drug-metabolizing enzymes in the human fetus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411555     DOI: 10.1111/j.1432-1033.1985.tb09107.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

Review 1.  Fetal drug metabolism and its possible clinical implications.

Authors:  B Krauer; P Dayer
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

2.  Pharmacokinetics of midazolam during continuous infusion in critically ill neonates.

Authors:  E Jacqz-Aigrain; P Daoud; P Burtin; S Maherzi; F Beaufils
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

4.  Microsomal epoxide hydrolase expression in the endometrial uterine corpus is regulated by progesterone during the menstrual cycle.

Authors:  Simone L Popp; Ina S Abele; Miriam B Buck; Matthias B Stope; Leen J Blok; Payman Hanifi-Moghaddam; Curt W Burger; Peter Fritz; Cornelius Knabbe
Journal:  J Mol Histol       Date:  2010-04-13       Impact factor: 2.611

5.  Differences in adult and foetal human cytochrome P-450 forms recognized by monoclonal antibodies with specificity for the P450III family.

Authors:  T S Barnes; M D Burke; W T Melvin
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

6.  The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population.

Authors:  Susan I Vear; Gregory D Ayers; Sara L Van Driest; Robert F Sidonio; Charles Michael Stein; Richard H Ho
Journal:  Br J Haematol       Date:  2014-03-06       Impact factor: 6.998

Review 7.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.

Authors:  K E Caudle; A E Rettie; M Whirl-Carrillo; L H Smith; S Mintzer; M T M Lee; T E Klein; J T Callaghan
Journal:  Clin Pharmacol Ther       Date:  2014-08-06       Impact factor: 6.875

9.  Age-related differences in susceptibility to cisplatin-induced renal toxicity.

Authors:  P Espandiari; B Rosenzweig; J Zhang; Y Zhou; L Schnackenberg; V S Vaidya; P L Goering; R P Brown; J V Bonventre; K Mahjoob; R D Holland; R D Beger; K Thompson; J Hanig; N Sadrieh
Journal:  J Appl Toxicol       Date:  2010-03       Impact factor: 3.446

10.  Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.

Authors:  P Beaune; P M Dansette; D Mansuy; L Kiffel; M Finck; C Amar; J P Leroux; J C Homberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.